Budesonide Inhalation Powder: A Review of Its Pharmacologic Properties and Role in the Treatment of Asthma

Budesonide inhalation powder, available as Pulmicort Turbuhaler, is a corticosteroid with a high ratio of local to systemic effects that is administered to treat persistent asthma. The Turbuhaler achieves lung deposition approximately twice that of a metered‐dose inhaler (MDI) with or without a spacer device. Budesonide inhalation powder has clinical efficacy equivalent to that of fluticasone and beclomethasone, but it has lower systemic bioavailability and fewer systemic side effects. As with other inhaled corticosteroids, dysphonia and oral candidiasis are the most frequent adverse effects, and systemic effects are infrequent. The initial starting dosage is 200 μg (1 puff) twice/day and may be increased to 800 μg twice/day in adults or 400 μg twice/day in children. Patients prefer the Turbuhaler to the MDI, Diskhaler, and Rotahaler because it is easier to use and more convenient to carry.

• Publication year

  1998

• Venue

  Pharmacotherapy

• Publication date

  1998-07-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/j.1875-9114.1998.tb03894.xPMID 9692646
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics of inhaled drugs.

  2003cited by this paper
• Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler.

  1997cited by this paper
• Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.

  1997cited by this paper
• Dose-Response of Inhaled Drugs in Asthma

  1997cited by this paper
• Changes in bone markers in children with asthma during inhaled budesonide and nedocromil treatments

  1996cited by this paper
• Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.

  1996cited by this paper
• Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: a controlled study.

  1996cited by this paper
• Home assessment of peak inspiratory flow through the Turbohaler in asthmatic patients.

  1996cited by this paper
• Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).

  1996cited by this paper
• Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.

  1996cited by this paper
• The Pharmacologic Approach to the Critically Ill Patient

  1995cited by this paper
• Optimizing inhaled drug delivery in patients with asthma.

  1995cited by this paper
• Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma.

  1995cited by this paper
• Budesonide inhaled via Turbuhaler: a more effective treatment for asthma than beclomethasone dipropionate via Rotahaler.

  1995cited by this paper
• High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group.

  1995cited by this paper
• Local side‐effects during 4‐year treatment with inhaled corticosteroids – a com between pressurized metered‐dose in and Turbuhaler®

  1994cited by this paper
• Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI.

  1994cited by this paper
• Clinical efficacy of budesonide Turbuhaler® compared with that of beclomethasone dipropionate pMDI with volumatic spacer

  1994cited by this paper
• Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma.

  1994cited by this paper
• Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma.

  1994cited by this paper
• Local side-effects during 4-year treatment with inhaled corticosteroids--a comparison between pressurized metered-dose inhalers and Turbuhaler.

  1994cited by this paper
• Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects.

  1994cited by this paper
• The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler.

  1993cited by this paper
• Importance of the inhalation device on the effect of budesonide.

  1993cited by this paper
• Effects of dose and dosing schedule of inhaled budesonide on bone turnover.

  1991cited by this paper
• Metered dose pressurized aerosols and the ozone layer.

  1990cited by this paper
• Exercise-induced asthma and the generation of neutrophil chemotactic activity.

  1990cited by this paper
• Brief inhalation of asbestos compromises superoxide production in cells from bronchoalveolar lavage.

  1990cited by this paper
• Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity.

  1989cited by this paper
• Breath-actuated inhalers: comparison of terbutaline Turbohaler with salbutamol Rotahaler.

  1989cited by this paper
• Bioequivalent doses of budesonide and prednisone in moderate and severe asthma.

  1989cited by this paper
• Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid.

  1982cited by this paper
• Problems patients have using pressurized aerosol inhalers.

  1982cited by this paper
• Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man.

  1982cited by this paper

• A stretchable human lung-on-chip model of alveolar inflammation for evaluating anti-inflammatory drug response.

  2024cites this paper
• A Randomized Comparison of Effects of Budesonide Spray and K-Y Gel as an Endotracheal Tube Cuff Lubricant on Incidence of Postoperative Sore Throat.

  2023cites this paper
• Inhaled Corticosteroids and Voice Problems. What Is New?

  2017cites this paper
• Chronic Lung Disease in Preterm Infants: A Pilot Study Early Intratracheal Instillation of Budesonide Using Surfactant as a Vehicle to Prevent

  2015cites this paper
• Once-Daily Inhaled Corticosteroids in Mild to Moderate Asthma

  2012cites this paper
• Inhaled corticosteroids: hazardous effects on voice-an update.

  2007cites this paper
• İnhaler Steroid Kullanan Bronşiyal Astımlılarda Disfoninin Değerlendirilmesi

  2005cites this paper
• Gamma Scintigraphic Evaluation of a Novel Budesonide Dry Powder Inhaler Using a Validated Radiolabeling Technique

  2002cites this paper
• The clinical effectiveness and cost-effectiveness of inhaler devices used in the routine management of chronic asthma in older children: a systematic review and economic evaluation.

  2002cites this paper
• Inhalational and topical steroids, and oral candidosis: a mini review.

  2001cites this paper
• Dysphonia associated with inhaled steroids.

  2000cites this paper
• Effect of budesonide and salbutamol on surfactant properties.

  2000cites this paper
• Budesonide Inhalation Powder: A Review of its Pharmacologic Properties and Role in the Treatment of Asthma — Another View

  1999cites this paper